ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
Antonio Bertolotto
Antonio Bertolotto Antonio Bertolotto
Regional Reference Multiple Sclerosis Centre
University Hospital San Luigi Gonzaga of Orbassano

Antonio Bertolotto, graduated in Medicine and specialized in Neurology at the University of Turin. He worked as Clinical Neurologist in the University of Turin till 1992, then he moved to the new Second Medical School of the University of Turin at S. Luigi Hospital, Orbassano (Turin), where he created the Multiple Sclerosis Clinic (CRESM = Centro Riferimento Regionale Sclerosi Multipla) that includes the Clinical Neurobiology Laboratory and the Experimental Neurophysiology Laboratory. Dr. Bertolotto is involved in both clinical activity and research in MS. The Clinical Neurobiology Laboratory serves as the Italy centre for the detection of antibodies neutralizing Interferon beta and Natalizumab. The research at the MS centre and Clinical Neurobiology Laboratory is focused on the identification of Disease Modifying Treatments non-responders, on evaluating the effects of pregnancy on gene-expression, on haematopoietic stem cell transplantation project and in several other clinical trials. Dr. Bertolotto is member of the scientific board of the Italian Association for MS and of the ”Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology” for Interferon beta Neutralizing antibodies.

Research Interest

Clinical activity and research in Multiple Sclerosis.


Global Speakers in the subject

Global Experts in the subject


Cyclophosphamide Pulses Therapy after Natalizumab Discontinuation for Multiple Sclerosis: A Multicentre Study

Marco Capobianco, Marianna Lo Re, Francesca Sangalli, Lucia Moiola, Paola Perini, Paolo Gallo, Maura Danni, Leandro Provinciali, Annamaria Repice, Luca Massacesi, Silvia Messina, Francesco Patti, Alice Laroni8, Gian Luigi Mancardi, Eugenio Pucci, Massimiliano Calabrese, Antonio Bertolotto

Research Article: J Mult Scler (Foster City)
doi: 10.4172/2376-0389.1000151
OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version